Unique ID issued by UMIN | UMIN000043825 |
---|---|
Receipt number | R000050020 |
Scientific Title | Safety evaluation of an excessive consumption of food material - Randomized, double-blind, placebo-controlled parallel group study - |
Date of disclosure of the study information | 2021/04/02 |
Last modified on | 2021/10/01 18:29:11 |
Safety evaluation of an excessive consumption of food material
- Randomized, double-blind, placebo-controlled parallel group study -
Safety evaluation of an excessive consumption of food material
Safety evaluation of an excessive consumption of food material
- Randomized, double-blind, placebo-controlled parallel group study -
Safety evaluation of an excessive consumption of food material
Japan |
Not applicable
Adult |
Others
NO
To evaluate the safety of excessive consumption of food material for 4
weeks
Safety
Expression rate of side effect, Expression rate of Adverse event , clinical examination items, physiological examination items
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Test food
5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks.
Control food
5 times of serving size per day for 4 weeks, safety evaluations are performed at 0, 2, 4 and 6 weeks.
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Males and females equal to or more than 20 years and less than 65 years of age
2)Subjects who visit on schedule days
3)Subjects who recognize the object and contents of the study and submit the written informed consent
1)Subjects who BMI >=30.0 kg/m2 or <18.5 kg/m2
2)Subjects who have systolic blood pressure <90 mmHg
3)Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study
4)Subjects who have a history of severe illness and current medical history in the heart, liver, kidney, digestive organs
5)Subjects who regularly use drugs, health foods, and supplements
6)Females in pregnancy, lactation and scheduled pregnancy during test period.
7)Heavy alcoholic beverager(40g alcohol/day>=), heavy smoker(21 cigarettes/day>=)
8)Subjects who feel bad mood by blood collection in past
9)Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period
10)Night shift worker
11)Don't usually have breakfast
12)Subjects who plan business trip or trip for 10 days or more a month
13)Subjects who have allergy related to the study foods
14)Those who have been diagnosed with chronic constipation
15)Dysphagic person
16)Subjects already participating in other clinical trials
17)Subjects who are ineligible due to physician's judgement
50
1st name | Ikuo |
Middle name | |
Last name | Fukuhara |
Fukuhara Clinic
Hospital director
061-1351
3-1-15 Shimamatsuhigashi-machi, Eniwa, Hokkaido, Japan
0123-36-8029
i-feniwa@gray.plala.or.jp
1st name | Toyotada |
Middle name | |
Last name | Ashino |
New drug research center, Inc.
Clinical Research Dept.
061-1405
452-1 Toiso, Eniwa-shi, Hokkaido, Japan
0123-34-0412
t-ashino@ndrcenter.co.jp
Maruzen Pharmaceuticals Co., Ltd
Maruzen Pharmaceuticals Co., Ltd
Profit organization
Fukuhara Clinic Clinical Trial Review Committee
1-15, Shimamatsuhigashimachi-3-chome, Eniwa-shi, Hokkaido
0123-36-8029
d-kameda@mediffom.co.jp
NO
2021 | Year | 04 | Month | 02 | Day |
Unpublished
Completed
2021 | Year | 03 | Month | 24 | Day |
2021 | Year | 03 | Month | 22 | Day |
2021 | Year | 04 | Month | 26 | Day |
2021 | Year | 06 | Month | 23 | Day |
2021 | Year | 04 | Month | 02 | Day |
2021 | Year | 10 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050020